KRISTEN YOUNG: Open Payments
NPI 1083257448 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,634 in 115 payments from 16 companies in 2025. Trend: 2023 $3,297 · 2024 $2,114 · 2025 $2,634
Food & beverage: $2,634
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $697 |
| Janssen Biotech, Inc. | 14 | $416 |
| Janssen Scientific Affairs, LLC | 2 | $281 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $217 |
| QOL Medical, LLC | 6 | $192 |
| PFIZER INC. | 13 | $156 |
| GENZYME CORPORATION | 5 | $153 |
| Novo Nordisk Inc | 4 | $147 |
| Celltrion USA Inc. | 3 | $71 |
| Gilead Sciences, Inc. | 3 | $70 |
Products named: TREMFYA, RINVOQ, Sucraid, XIFAXAN, DUPIXENT, Wegovy, LINZESS, CREON.
Industry payments across TX — which companies pay providers there.
